This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
A clinical summary of this KDP was published in the Journal of the Ministry of Health of the Czech Republic .
Diabetes mellitus is a heterogeneous group of diseases whose uniform laboratory manifestation is hyperglycemia. In 2017, the number of diabetics in the Czech Republic was 995,613, of which 762,...
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease, damage to eyes, kidneys and nerves, and premature death. Globally, more than 400 million adults live with diabetes, and diabetes directly caused 1....
Farrell, B;
Black, C;
Thompson, W;
McCarthy, L;
Rojas-Fernandez, C;
Lochnan, H;
Shamji, S;
Upshur, R;
Bouchard, M;
Welch, V.
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...
Jacobi, J;
Bircher, N;
Krinsley, J;
Agus, M;
Braithwaite, S. S;
Deutschman, C;
Freire, A. X;
Geehan, D;
Kohl, B;
Nasraway, S. A;
Rigby, M;
Sands, K;
Schallom, L;
Taylor, B;
Umpierrez, G;
Mazuski, J;
Schunemann, H.
Objective: To evaluate the literature and identify important aspects of insulin therapy that facilitate safe and effective infusion therapy for a defined glycemic end point. Methods: Where available, the literature was evaluated using Grades of Recommendation, Assessment, Development, and Evaluation (GRA...
